What the FDA labels say about taking them together
Gemfibrozil and warfarin
Gemfibrozil's FDA label of April 10, 2026 names warfarin in its drug interactions section; the warfarin label PlainMeds reads does not name gemfibrozil.
Check it at the source: the gemfibrozil FDA label on DailyMed (effective April 10, 2026, Northstar RxLLC); the warfarin FDA label on DailyMed (effective May 29, 2026, Amneal Pharmaceuticals LLC).
What does the gemfibrozil label say about warfarin?
Gemfibrozil label, drug interactions(B) Anti-coagulants: CAUTION SHOULD BE EXERCISED WHEN WARFARIN IS GIVEN IN CONJUNCTION WITH GEMFIBROZIL.
Gemfibrozil label, warningsConcomitant Anticoagulants-Caution should be exercised when warfarin is given in conjunction with gemfibrozil.
Source: FDA drug label (Lopid, NDA018422), Parke-Davis Div of Pfizer Inc, effective May 21, 2026 (SPL set c48855b7-215e-453b-b3b1-a0f9dee7221f), via openFDA
Source: FDA drug label (Gemfibrozil), Northstar RxLLC, effective April 10, 2026 (SPL set 75cac02c-56e3-4dfe-b1e2-4ce166b28833), via openFDA; the full label on DailyMed
What does the warfarin label say about gemfibrozil?
Warfarin's label (effective May 29, 2026) does not name gemfibrozil in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Warfarin Sodium), Amneal Pharmaceuticals LLC, effective May 29, 2026 (SPL set 558b7a0d-5490-4c1b-802e-3ab3f1efe760), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Gemfibrozil | Warfarin | |
|---|---|---|
| Labeled for | High cholesterol, Heart attack and coronary artery disease | Blood clots (DVT and PE), Atrial fibrillation |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | $0.104 per tablet 600 mg tablet | $0.093 per tablet 2 mg tablet |
| Shortage now | A presentation being discontinued | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once